“…Though the two residues have the same net charge, switching the guanidinium groups of arginine for the amine groups of lysine has been shown to decrease the antimicrobial activity, membrane disruptive ability, and cytotoxicity for many AMPs [8, 9, 7, 10], including tritrpticin [11, 6], human neutrophil peptide 1 [12], and KR-12 [13]. Likewise, synthetic peptidomimetics containing amine side chains were shown to be less active against eight bacterial strains than those containing guanidinium groups and, unlike their guanidinium-containing counterparts, do not disrupt DPPG monolayers [14]. Studies comparing arginine and lysine oligomers have shown that polyarginine enters cells far more efficiently than polylysine [15], and binds more strongly to both POPC and mixed POPC/POPG bilayers [16].…”